THE prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia, stated pharmacy industry insurer Pharmaceutical Defence Limited (PDL) yesterday.
With this emerging field comes the need for comprehensive risk management considerations and strategies in pharmacy to ensure patient safety and regulatory compliance.
PDL has put out the following key points that explore some essential risk management considerations for pharmacists who are involved in this area of practice HERE.
The insurer has also put out a practice alert to make pharmacists aware that off-label prescribing is not uncommon, and the profession plays a vital role to ensure patient safety and promote the appropriate use of medicines.
Learn more about the obligations, responsibilities and risk mitigation strategies for pharmacists in relation to the supply of medicines when prescribed off-label HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 23
